From: Serum defensin levels in patients with systemic sclerosis
Clinical manifestations | No involvement | Involvement present | P values |
---|---|---|---|
Interstitial lung disease | 430 [140–595] (n = 22) | 684 [324–1152] (n = 20) | 0.04* |
Pulmonary hypertension | 503 [139–888] (n = 31) | 624 [300–991] (n = 11) | 0.4 |
Raynaud’s phenomenon | 512 (n = 1) | 564 [157–890] (n = 41) | 0.95 |
Telangiectasia | 621 [388–894] (n = 22) | 498 [135–879] (n = 20) | 0.29 |
Digital Ulcer | 583 [165–938] (n = 26) | 529 [164–813] (n = 16) | 0.56 |
Esophageal Involvement | 588 [352–890] (n = 29) | 506 [124–933] (n = 13) | 0.34 |